Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-24-001994

SVP, Chief Operating Officer sold 10,744 shares at $1.52 ($16,331)

From the SEC's structured data for this filing

Trades in this filing

Dahan Michel · SVP, Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-27 Sale : show line 1 in the form −10,744 $1.52 $16,331 715,593 D
Open-market sales · 10,744 sh · avg $1.52 · $16,331
Loading xslF345X05/primarydocument.xml…